PRIMATE MODELS IN PSYCHOPHARMACOLOGY

PRIMATE MODELS IN PSYCHOPHARMACOLOGY

Bibliographic Details
Main Authors:	Rupniak, N, Iversen, S
Format:	Journal article
Published:	1988

Similar Items

Cognitive impairment in schizophrenia: how experimental models using nonhuman primates may assist improved drug therapy for negative symptoms.
by: Rupniak, N, et al.
Published: (1993)

Comparison of the effects of selective and nonselective muscarinic agonists on cognition and thermoregulation in primates.
by: Rupniak, N, et al.
Published: (1992)

Direct comparison of cognitive facilitation by physostigmine and tetrahydroaminoacridine in two primate models.
by: Rupniak, N, et al.
Published: (1990)

Psychopharmacology /
by: Ettinger, R. H., author 267865
Published: (2017)

Colour preferences in the pigeon: a behavioural and psychopharmacological study.
by: Sahgal, A, et al.
Published: (1975)

Anxiolytic-like and antinociceptive effects of MK-801 accompanied by sedation and ataxia in primates.
by: Rupniak, N, et al.
Published: (1993)

Psychomotor activity and cognitive disruption attributable to NMDA, but not sigma, interactions in primates.
by: Boyce, S, et al.
Published: (1991)

Evidence against a specific effect of cholinergic drugs on spatial memory in primates.
by: Rupniak, N, et al.
Published: (1991)

Differential effects of D1 and D2 agonists in MPTP-treated primates: functional implications for Parkinson's disease.
by: Boyce, S, et al.
Published: (1990)

Failure of d-cycloserine to reverse cognitive disruption induced by scopolamine or phencyclidine in primates.
by: Rupniak, N, et al.
Published: (1992)

Differential effects of D1 and D2 agonists in MPTP-treated primates: functional implications for Parkinson's disease. 1990.
by: Boyce, S, et al.
Published: (2001)

PSYCHOPHARMACOLOGICAL PROFILE OF THE NMDA RECEPTOR ANTAGONIST MK-801
by: Iversen, S, et al.
Published: (1987)

Weak antiparkinsonian activity of the D1 agonist C-APB (SKF 82958) and lack of synergism with a D2 agonist in primates.
by: Rupniak, N, et al.
Published: (1992)

Fundamentals of psychopharmacology /
by: 356043 Leonard, B. E.
Published: (2003)

Psychopharmacology of Addiction
by: Tugce Toker Ugurlu, et al.
Published: (2012-03-01)

Comparison of the effects of four cholinomimetic agents on cognition in primates following disruption by scopolamine or by lists of objects.
by: Rupniak, N, et al.
Published: (1989)

Reversal of cognitive impairment by heptyl physostigmine, a long-lasting cholinesterase inhibitor, in primates.
by: Rupniak, N, et al.
Published: (1992)

No psychiatry without psychopharmacology.
by: Harrison, P, et al.
Published: (2011)

The psychotherapist's guide to psychopharmacology /
by: 279572 Gitlin, Michael J.
Published: (1996)

The role of psychopharmacology in suicide prevention.
by: Saunders, K, et al.
Published: (2009)

Psychopharmacology of moral and social judgments
by: Terbeck, S
Published: (2012)

PSYCHOPHARMACOLOGIC TARGETS IN PERSONALIZED PSYCHIATRY
by: Neamtu Monica
Published: (2022-05-01)

Editorial: Case reports in psychopharmacology
by: Matej Stuhec, et al.
Published: (2024-01-01)

Manual of generalities on geriatric psychopharmacology.
by: Juan Rafael Cordero Jiménez, et al.
Published: (2006-04-01)

Psychopharmacology and Biological Studies of Psychosis
by: Marcin Siwek, et al.
Published: (2023-05-01)

Manual of generalities on geriatric psychopharmacology.
by: Juan Rafael Cordero Jiménez, et al.
Published: (2006-04-01)

Use of psychopharmacological drugs in ER
by: Vincenzo Villari
Published: (2008-10-01)

Anticholinergic Drugs in Geriatric Psychopharmacology
by: Jorge López-Álvarez, et al.
Published: (2019-12-01)

THE PSYCHOPHARMACOLOGY INTO PSYCHOLOGIST’S FORMATION AND PRACTICE.
by: Silvia Anahí de la Mano
Published: (2010-06-01)

Psychological and Psychopharmacological Interventions in Psychocardiology
by: Kai G. Kahl, et al.
Published: (2022-03-01)

Child and adolescent clinical psychopharmacology
by: Rubens Reimão
Published: (1997-06-01)

9th International Congress on Psychopharmacology & 5th International Symposium on Child and Adolescent Psychopharmacology
by: Abdurrahim Bakirhan, et al.
Published: (2017-03-01)

11th International Congress on Psychopharmacology & 7th International Symposium on Child and Adolescent Psychopharmacology
Published: (2019-08-01)

9th International Congress on Psychopharmacology & 5th International Symposium on Child and Adolescent Psychopharmacology
by: Muharrem Burak Baytunca, et al.
Published: (2017-03-01)

11th International Congress on Psychopharmacology & 7th International Symposium on Child and Adolescent Psychopharmacology
Published: (2019-08-01)

11th International Congress on Psychopharmacology & 7th International Symposium on Child and Adolescent Psychopharmacology
Published: (2019-08-01)

9th International Congress on Psychopharmacology & 5th International Symposium on Child and Adolescent Psychopharmacology
by: Hatice Dogan, et al.
Published: (2017-03-01)

9th International Congress on Psychopharmacology & 5th International Symposium on Child and Adolescent Psychopharmacology
by: Özge Şahmelikoğlu Onur, et al.
Published: (2017-03-01)

9th International Congress on Psychopharmacology & 5th International Symposium on Child and Adolescent Psychopharmacology
by: Mine Elagoz Yuksel, et al.
Published: (2017-03-01)

11th International Congress on Psychopharmacology & 7th International Symposium on Child and Adolescent Psychopharmacology
Published: (2019-08-01)